2024 annual financial data
Ovid Therapeutics 2024 Financial results
Direct answer
Revenue was 566,000 USD.
Operating income was -61.89M USD and net income was -26.43M USD.
Operating cash flow was -55.96M USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 566,000 USD
- Operating income
- -61.89M USD
- Net income
- -26.43M USD
- Operating cash flow
- -55.96M USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Ovid Therapeutics financial years